30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Reduction of Side Effects by Protecting the Tongue as Organ at Risk: A Planning/Feasibility Study
Andrea Renate Glasmacher et al. | Abstract 1810 | ESTRO | 2024
SBRT Versus ENRT for Lymph-nodal Relapses in Gynaecological Cancers
Martina Midulla et al. | Abstract 2783 | ESTRO | 2024
Acute Toxicity from PACE-C Comparing Stereotactic Body Radiotherapy (SBRT) with Moderate Hypofractionation (MHRT)
Alison Tree et al. | Abstract 3395 | ESTRO | 2024
Adaptive RT Concomitant to Oxaliplatin Based Chemotherapy as Preoperative Treatment for Rectal Cancer
Giorgio Purrello et al. | Abstract 2304 | ESTRO | 2024
Reappraising Prognostic Factors after SRS/FSRT of Brain Metastases in the era of Targeted Therapies
Christoph A Fink et al. | Abstract 1044 | ESTRO | 2024
Independent Validation of Real-time Prostate Localization for MLC Tracking in Phantoms and Patients
Klara Stefansson et al. | Abstract 757 | ESTRO | 2024
Dose Tracking in Head and Neck Cancer – Possible Benefits with Adaptive Radiotherapy
Hedda Enocson et al. | Abstract 1210 | ESTRO | 2024
Intensified Total Marrow Irradiation in High-risk HSCT Patients
Simonetta Saldi et al. | Abstract 3109 | ESTRO | 2024
Preoperative Single-fraction RT for Earlystage BC: Preliminary Results from CRYSTAL Phase I/II Study
Maria Alessia Zerella et al. | Abstract 2613 | ESTRO | 2024
Outcomes of a Phase II Trial of High-dose Online-Adaptive SBRT for Abdominal Oligometastases
Lucy A. van Werkhoven et al. | Abstract 613 | ESTRO | 2024
Patterns of Care and Outcome of Liver SBRT: Results from a Multicentre National Quality Project
Pieter Deseyne et al. | Abstract 735 | ESTRO | 2024
Outcomes of Pelvic Reirradiation with Stereotactic Radiotherapy for Gynaecological Cancer Recurrence
Benjamin J Thomas et al. | Abstract 2829 | ESTRO | 2024
Modern radiotherapy for extended cutaneous lesions from lymphomas: results from a multicenter study
Mario Levis et al. | Abstract 1270 | ESTRO | 2024
Efficacy and toxicity of moderately hypofractionated radiotherapy via helical TomoTherapy versus conventional radiotherapy combined with concurrent chemotherapy for patients with unresectable stage III non-small cell Lung Cancer: a multicenter, randomized phase III trial Chinese clinical trial registration: ChiCTR1800017367
Huang Wenhan et al. | Abstract 3407 | ESTRO | 2024
Automation of the Couch Sag Quality Control Test for Accuray Radixact
Guillermo Camacho et al. | Abstract 2309 | ESTRO | 2024
Stereotactic Radiotherapy and Radiosurgery vs Fractionated Radiotherapy for Head and Neck Paragangliomas
Laura Giannini et al. | Abstract 1847 | ESTRO | 2024
Quality of Life in Head and Neck Cancer Patients – A Prospective Longitudinal Study (FEMH 110183-E)
Yu-Hsuan Chuang et al. | Abstract 1499 | ESTRO | 2024
Initial Clinical and Dosimetric Outcomes with TBI Planned on Helical TomoTherapy
Varghese Antony et al. | Abstract 2797 | ESTRO | 2024
Clinical Outcome and Dosimetric Feasibility of Hippocampal Sparing Whole Brain Radiotherapy
Bhuvana J et al. | Abstract 1546 | ESTRO | 2024
Moderate Hypofractionation with Simultaneous Integrated Boost after Conservative Surgery for Breast Cancer
Roberta Tummineri et al. | Abstract 2485 | ESTRO | 2024
Left Breast Cancer Dosimetry with Accuray VOLO Ultra Optimizer: A Comparison with DIBH
Patrizia Urso et al. | Abstract 1363 | ESTRO | 2024
Radiation-related Lymphopenia Post Prostate Stereotactic Body Radiation Therapy ± Pelvic Irradiation
Kelly Gaudian et al. | Abstract 1368 | ESTRO | 2024
A Proof of Concept for MR-only Workflow in CyberKnife Intracranial Radiosurgery
Evaggelos Pantelis et al. | Abstract 2146 | ESTRO | 2024